Literature DB >> 8580273

Erythromycin shortens orocaecal transit time in diabetic male subjects: a double-blind placebo-controlled study.

A Minocha1, R Katragadda, P S Rahal, A Ries.   

Abstract

BACKGROUND: The effects of erythromycin on small bowel motility are controversial. Orocaecal transit time (OCTT) is considered to be a valid measure of small bowel motility.
METHODS: We studied the effect of erythromycin on OCTT in diabetic male subjects in a double-blind placebo-controlled crossover fashion. After an overnight fast, subjects received erythromycin 500 mg, 250 mg or placebo, on 3 different days. A standard solid meal containing 20 g lactulose was administered 30 min after the erythromycin ingestion. Exhaled breath was collected and hydrogen concentration was assessed over 5 h. Breath hydrogen concentrations for each session were analysed over time by a generalized logistic function generating a sigmoidal curve. Front transit time was recorded as the time point when a sustained rise in breath hydrogen concentration of at least 5 p.p.m. was first observed.
RESULTS: The mean +/- S.E.M. time taken for the front of the meal to reach the caecum was 92.5 +/- 9.5, 86.1 +/- 16.5 and 62.3 +/- 12.1 min for placebo, erythromycin 250 mg and erythromycin 500 mg, respectively. The OCTT was significantly decreased with erythromycin 500 mg compared to placebo (P < 0.05).
CONCLUSION: Oral administration of 500 mg erythromycin has prokinetic effect on orocaecal transit in male patients with diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8580273     DOI: 10.1111/j.1365-2036.1995.tb00416.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  8 in total

1.  Chronic Intestinal Pseudo-obstruction.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-06

2.  Cisapride reduces neonatal postoperative ileus: randomised placebo controlled trial.

Authors:  A Lander; R Redkar; G Nicholls; A Lawson; S R Choudhury; J J Corkery; P Gornall; R G Buick; I W Booth
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-09       Impact factor: 5.747

3.  Effect of oral erythromycin on gastric and small bowel transit time of capsule endoscopy.

Authors:  Wai K Leung; Francis K L Chan; Sara S L Fung; Mei-Yin Wong; Joseph J Y Sung
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

4.  Effect of erythromycin on gastric emptying in healthy individuals assessed by radio-opaque markers and plasma acetaminophen levels.

Authors:  H J Park; J K Jung; K S Song; S I Lee; Z Itoh; I S Park
Journal:  J Gastroenterol       Date:  1997-12       Impact factor: 7.527

5.  Effect of different prokinetic agents and a novel enterokinetic agent on postoperative ileus in rats.

Authors:  B Y De Winter; G E Boeckxstaens; J G De Man; T G Moreels; J A Schuurkes; T L Peeters; A G Herman; P A Pelckmans
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

Review 6.  [Gastrointestinal complications of diabetes mellitus].

Authors:  M Vogt; H E Adamek; J C Arnold; D Schilling; T Schleiffer; J F Riemann
Journal:  Med Klin (Munich)       Date:  1999-06-15

7.  Efficacy of Pro-Kinetic Agents in Type 2 Diabetes Mellitus Patients With Gastroparesis Using Lactulose Hydrogen Breath Testing: A Randomized Trial.

Authors:  Prakash Tendulkar; Ravi Kant; Satyavati Rana; Poonam Yadav; Anissa A Mirza; Disha Agarwal
Journal:  Cureus       Date:  2022-01-06

Review 8.  European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus.

Authors:  Heinz F Hammer; Mark R Fox; Jutta Keller; Silvia Salvatore; Guido Basilisco; Johann Hammer; Loris Lopetuso; Marc Benninga; Osvaldo Borrelli; Dan Dumitrascu; Bruno Hauser; Laszlo Herszenyi; Radislav Nakov; Daniel Pohl; Nikhil Thapar; Marc Sonyi
Journal:  United European Gastroenterol J       Date:  2021-08-25       Impact factor: 4.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.